MARGO:基于重叠权重的机器学习辅助群序贯试验适应性随机化
本文提出MARGO方法,将机器学习模型融入群序贯试验的适应性随机化过程,利用重叠权重平衡协变量以控制I类错误。模拟研究表明,MARGO在保持统计严谨性的同时提升了试验的灵活性和效率,可能提高治疗成功率。
要点
- MARGO将机器学习预测与适应性随机化结合,动态更新分配概率。
- 采用重叠权重平衡协变量,以控制群序贯试验的总体I类错误率。
- 模拟研究显示MARGO在控制I类错误率的同时提升灵活性与效率。
核心结论
- MARGO在模拟研究中不仅提升了群序贯试验的灵活性和效率,还通过有效控制I类错误率保持了统计严谨性。
- MARGO提供了一种更符合伦理且数据驱动的患者分配方式,可能提高治疗成功率并维护试验完整性。
研究设计与样本
- 本文提出MARGO方法,将机器学习模型整合到群序贯试验的适应性随机化过程中。
- 通过广泛的模拟研究评估MARGO的性能,并比较多种机器学习算法预测治疗结局的效果。
主要发现
- 模拟研究表明MARGO能够基于实时预测动态更新随机化概率。
- MARGO利用重叠权重平衡治疗组间协变量,以最小化混杂并确保治疗比较无偏。
- MARGO在模拟研究中有效控制了总体I类错误率。
关键数值与推荐
- MARGO采用重叠权重(OW)来平衡协变量,以控制因协变量不平衡导致的总体I类错误率。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Adaptive randomization is a promising approach in clinical trials that aims to optimize patient outcomes by adjusting treatment allocation probabilities based on accumulating data. However, implementing adaptive randomization in group sequential trials, which include interim analyses for early stopping decisions, poses significant challenges, such as managing type I error inflation and ensuring robust statistical validity. This paper proposes Machine learning-assisted Adaptive Randomization for Group sequential trials based on Overlap weights (MARGO) as an innovative solution to these challenges. MARGO integrates machine learning (ML) models into the adaptive randomization process, allowing dynamic updates to randomization probabilities based on real-time predictions of treatment success. To control the overall type I error rate due to the covariate imbalance in group sequential trials, MARGO utilizes overlap weights (OW), which are employed to balance covariates across treatment groups, minimizing confounding and ensuring that the comparison between treatments remains unbiased. In our implementation, various ML algorithms are evaluated for their effectiveness in predicting treatment outcomes. Through extensive simulation studies, we demonstrate that MARGO not only enhances the flexibility and efficiency of group sequential trials but also maintains statistical rigor by effectively controlling type I error rates. Our results show that MARGO provides a more ethical and data-driven approach to patient allocation, potentially improving treatment success rates while preserving the integrity of the trial.
引用
- Park Y, Nycklemoe S. MARGO: Machine Learning-Assisted Adaptive Randomization for Group Sequential Trials Based on Overlap Weights. Stat Med. 2025. PMID: 40662505. doi:10.1002/sim.70158
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。